Kamada Ltd. (TLV:KMDA)
2,282.00
+7.00 (0.31%)
May 19, 2026, 11:49 AM IDT
Kamada Revenue
Kamada had revenue of $45.24M USD in the quarter ending March 31, 2026, with 2.78% growth. This brings the company's revenue in the last twelve months to $181.68M, up 8.64% year-over-year. In the year 2025, Kamada had annual revenue of $180.46M with 12.12% growth.
Revenue (ttm)
$181.68M
Revenue Growth
+8.64%
P/S Ratio
2.29
Revenue / Employee
$393.25K
Employees
462
Market Cap
1.31B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 180.46M | 19.51M | 12.12% |
| Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
| Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
| Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
| Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 54.78B |
| Rekah Pharmaceutical Industry | 300.99M |
| InterCure | 270.20M |
| Seach Medical Group | 157.15M |
| Together Pharma | 109.63M |
| Tikun Olam-Cannbit Pharmaceuticals | 9.10M |
| Nextage Therapeutics | 243.00K |
Kamada News
- 5 days ago - Kamada (KMDA) Maintains 2026 Financial Projections - GuruFocus
- 5 days ago - Kamada (KMDA) Reports Strong Q1 Revenue Growth - GuruFocus
- 5 days ago - Kamada Releases Q1 2026 Financial Results - AlphaStreet
- 5 days ago - Kamada Earnings Call Transcript: Q1 2026 - Transcripts
- 5 days ago - Kamada reports Q1 EPS 7c, consensus 12c - TheFly
- 5 days ago - Kamada backs FY26 revenue view $200M-$205M - TheFly
- 5 days ago - Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year - GlobeNewsWire
- 10 days ago - Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics - Nasdaq